{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:01Z","timestamp":1793039461915,"version":"4.5.0"},"reference-count":65,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"unspecified","delay-in-days":173,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Clearside Biomedical"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2021,6,3]]},"DOI":"10.1080\/17425247.2021.1867532","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T07:59:21Z","timestamp":1609747161000},"page":"777-788","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":72,"title":["Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies"],"prefix":"10.1080","volume":"18","author":[{"given":"Shelley E.","family":"Hancock","sequence":"first","affiliation":[{"name":"Clearside Biomedical Inc., Alpharetta, GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Rei","family":"Wan","sequence":"additional","affiliation":[{"name":"Clearside Biomedical Inc., Alpharetta, GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan E.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Clearside Biomedical Inc., Alpharetta, GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael V.","family":"Andino","sequence":"additional","affiliation":[{"name":"Clearside Biomedical Inc., Alpharetta, GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5557-6777","authenticated-orcid":false,"given":"Thomas A.","family":"Ciulla","sequence":"additional","affiliation":[{"name":"Clearside Biomedical Inc., Alpharetta, GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.021"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2017.0121"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.07.013"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.02.021"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.03.001"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2018.03.008"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.01.006"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S89784"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.10.010"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14042"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.03.027"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000143"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.5.6.14"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.05.045"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017140"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002279"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2014.02.020"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.1998.760502.x"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029692"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)80096-8"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000212220.42675.c5"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2009.11.001"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9872"},{"issue":"2","key":"cit0024","first-page":"233","volume":"30","author":"Emi K","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2009.12.002"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1186\/2040-2384-2-14"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2016.03.008"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1997.tb00245.x"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0271-y"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129085"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1606"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2019.0126"},{"key":"cit0033","unstructured":"Henry CR, Schefler AC, Wan CR, et al. Post Hoc Analysis of Clinical Suprachoroidal Injection Experience Across Retinal Disease Indications Retina Society Annual Meeting 2020. [cited 2020 Oct 22]. Available from: https:\/\/www.clearsidebio.com\/pdf\/2020\/henry-christopher-post-hoc-analysis.pdf"},{"issue":"7","key":"cit0034","first-page":"24","volume":"61","author":"Fisher N","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0035","unstructured":"Fisher N, Yoo J, Hancock SE, et al. A Novel Technique to Characterize Key Fluid Mechanic Properties of the Suprachoroidal Injection Procedure in an In Vivo Model Association for Research in Vision and Ophthalmology Annual Meeting 2018. [cited 2020 Oct 28]. Available from: https:\/\/www.clearsidebio.com\/?articleattachment=49"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20377"},{"issue":"7","key":"cit0037","first-page":"3615","volume":"61","author":"Savinainen A","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"cit0038","first-page":"320","volume":"61","author":"Nork TM","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2010.47"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.05.020"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2016.10.011"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119935"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20679"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1021\/ma00054a017"},{"key":"cit0045","unstructured":"FITC-Dextran Fluorescein isothiocyanate dextran. 2011."},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23758"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.03.001"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.304"},{"issue":"13","key":"cit0049","first-page":"5259","volume":"55","author":"Edelhauser HF","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"cit0050","first-page":"3694","volume":"61","author":"Hancock SE","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"cit0051","first-page":"3977","volume":"61","author":"Kaiser PK","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0052","unstructured":"Singer MA IOP Following Administration of Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA): Results from the Phase 3 PEACHTREE Clinical Trial for Uveitis Macula Society Annual Meeting 2020[cited 2020 Oct 12]. Available from: https:\/\/www.clearsidebio.com\/?articleattachment=83"},{"key":"cit0053","unstructured":"Merrill P. Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks: Results of the MAGNOLIA Phase 3 Extension Study American Society of Retina Specialists Annual Meeting 2019[cited 2020 Oct 12]. Available from: https:\/\/www.clearsidebio.com\/?articleattachment=64"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20180831-07"},{"issue":"7","key":"cit0055","first-page":"4954","volume":"61","author":"Barakat M","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.11.27"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0255-8"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.339"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-017-0076-9"},{"key":"cit0060","unstructured":"EYLEA (aflibcercept) [prescribing information]. Tarrytown, NY: Regeneron Pharmaceuticals, Inc; 2019."},{"key":"cit0061","unstructured":"LUCENTIS (ranibizumab) [prescribing information]. South San Francisco, CA: Genentech, Inc; 2018."},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5001001"},{"key":"cit0063","unstructured":"Yeh S Suprachoroidally Injected CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveitis: Results of the Phase 3 PEACHTREE Study American Society of Retina Specialists Annual Meeting 2018. [cited 2020 Oct 28]. Available from: https:\/\/www.clearsidebio.com\/Yeh__S._Suprachoroidally_Injected_CLS-TA_Improves_Visual_Acuity_and_Macular_Edema_in_Noninfectious_Uveities_Results_of_the_Phase_3_PEACHTREE_Study.pdf"},{"key":"cit0064","volume-title":"Financial Results and Operational Highlights","author":"Regenxbio Reports First Quarter 2020","year":"2020"},{"key":"cit0065","unstructured":"Aura Biosciences Presents Updated AU-011 Clinical Data at ARVO 2020.Press Releases. Cambridge, MA: Aura Biosciences, 2020. [cited 2020 Dec 23]. Available from: http:\/\/www.aurabiosciences.com\/news-archive\/2020\/6\/12\/aura-biosciences-presents-updated-au-011-clinical-data-at-arvo\u20132020"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2021.1867532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T10:27:11Z","timestamp":1624962431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2021.1867532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,3]]}},"alternative-id":["10.1080\/17425247.2021.1867532"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2021.1867532","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}